← Congress

Rep. Julie Johnson has disclosed 114 buys and 453 sales since Mar 2024

House · D-TX

Committees: Foreign Affairs, Homeland Security, House Administration, Joint Committee of Congress on the Library

114Buys
453Sales
28 daysMedian delay

Rep. Julie Johnson's record

3 months after each buy, from the first price a copier could get.

+6.3%Average
+2.0 ptsVs S&P 500
46 of 67Higher

67 buys since 2025 with 3 months of prices.

Bought most often

Every disclosure

Newest first. Members report amounts as ranges.

WYBuy

Weyerhaeuser Co

$1K to $15KAug 5
WYSell

Weyerhaeuser Co

$1K to $15KAug 5
WECSell

WEC Energy Group Inc

$1K to $15KAug 5
WECBuy

WEC Energy Group Inc

$1K to $15KAug 5
VRSKBuy

VERISK ANALYTICS Inc

$1K to $15KAug 5
VRSKSell

VERISK ANALYTICS Inc

$1K to $15KAug 5
VRSNSell

Verisign Inc

$1K to $15KAug 5
VRSNBuy

Verisign Inc

$1K to $15KAug 5
UDRBuy

UDR Inc

$1K to $15KAug 5
UDRSell

UDR Inc

$1K to $15KAug 5
CISell

Cigna Corp

$1K to $15KAug 5
CIBuy

Cigna Corp

$1K to $15KAug 5
NOWBuy

ServiceNow Inc

$1K to $15KAug 5
NOWSell

ServiceNow Inc

$1K to $15KAug 5
ROLSell

ROLLINS Inc

$1K to $15KAug 5
ROLBuy

ROLLINS Inc

$1K to $15KAug 5
DGXBuy

Quest Diagnostics Inc

$1K to $15KAug 5
DGXSell

Quest Diagnostics Inc

$1K to $15KAug 5
PEGSell

Public Service Enterprise Group Inc

$1K to $15KAug 5
PEGBuy

Public Service Enterprise Group Inc

$1K to $15KAug 5
PAYCBuy

Paycom Software Inc

$1K to $15KAug 5
PAYCSell

Paycom Software Inc

$1K to $15KAug 5
PAYXSell

Paychex Inc

$1K to $15KAug 5
PAYXBuy

Paychex Inc

$1K to $15KAug 5
MNSTBuy

Monster Beverage Corp

$1K to $15KAug 5
MNSTSell

Monster Beverage Corp

$1K to $15KAug 5
MDLZSell

Mondelez International Inc

$1K to $15KAug 5
MDLZBuy

Mondelez International Inc

$1K to $15KAug 5
TAPBuy

Molson Coors Beverage Company

$1K to $15KAug 5
TAPSell

Molson Coors Beverage Company

$1K to $15KAug 5
MDTSell

Medtronic PLC

$1K to $15KAug 5
MKCSell

McCormick & Co Inc

$1K to $15KAug 5
MKCBuy

McCormick & Co Inc

$1K to $15KAug 5
LYBBuy

LyondellBasell Industries NV

$1K to $15KAug 5
LYBSell

LyondellBasell Industries NV

$1K to $15KAug 5
KRSell

The Kroger Co

$1K to $15KAug 5
KRBuy

The Kroger Co

$1K to $15KAug 5
KEYBuy

KeyCorp

$1K to $15KAug 5
KEYSell

KeyCorp

$1K to $15KAug 5
IPSell

International Paper Co

$1K to $15KAug 5
IPBuy

International Paper Co

$1K to $15KAug 5
HONBuy

Honeywell International Inc

$1K to $15KAug 5
HONSell

Honeywell International Inc

$1K to $15KAug 5
GENSell

NortonLifeLock Inc

$1K to $15KAug 5
GENBuy

NortonLifeLock Inc

$1K to $15KAug 5
FISVBuy

Fiserv Inc

$1K to $15KAug 5
FISVSell

Fiserv Inc

$1K to $15KAug 5
FFIVSell

F5 Inc

$1K to $15KAug 5
FFIVBuy

F5 Inc

$1K to $15KAug 5
EQIXBuy

Equinix Inc

$1K to $15KAug 5
About Julie Johnson

Julie Johnson is a Democratic U.S. Representative for Texas's 32nd Congressional District, elected in November 2024 with over 60% of the vote after winning a competitive 10-way primary.( A former Texas state representative for three terms since 2018, she served on the Insurance and Judiciary & Civil Jurisprudence committees, passed 108 bills focused on patient protection and insurance reform, and authored Texas's first bipartisan Medicaid expansion bill; she earned accolades like Texas Monthly's 2019 'Freshman of the Year' and 'Champion of Medicine' from the Texas Medical Association.(

Johnson, an attorney and the first openly gay member of Congress from the South and first woman to represent her district, prioritizes consumer protection, healthcare access, reproductive freedom, housing affordability, and immigrant rights in Congress.( She has introduced legislation to aid homebuying and challenged ICE misconduct.( No public attention or reports detail stock trades by Johnson, including MMM, ABT, ABBV, APD, or GOOGL, under the STOCK Act in available sources.( Following 2025 redistricting by Texas Republicans, she is running for re-election in the new 33rd District.(

Written by Perplexity from public sources.

Disclosures come from STOCK Act filings. Returns start at the first open after a buy was disclosed. Not investment advice.